CD274 and non-small cell lung carcinoma: From a retrospective cohort of 33 NSCLC patients and prospective cohort of 39 NSCLC patients, they found that non-responders had an increase in EV PD-L1 protein expression at 9 weeks post-treatment compared to baseline [139].